哈兽研品牌怎么样 申请店铺

我要投票 哈兽研在兽药行业中的票数:257 更新时间:2025-04-29
哈兽研是哪个国家的品牌?「哈兽研」是 哈尔滨维科生物技术有限公司 旗下著名品牌。该品牌发源于黑龙江哈尔滨市,由创始人付董在1992年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力哈兽研品牌出海!将品牌入驻外推网,定制哈兽研品牌推广信息,可以显著提高哈兽研产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

哈兽研怎么样

成立于1992年,国内知名的全系列禽流感疫苗制造品牌,专业从事动物疫病防治用生物制品的研发、生产、销售、技术咨询与服务的兽用生物制品企业


哈尔滨维科生物技术有限公司(简称维科生物)是中国农业科学院哈尔滨兽医研究所(简称哈兽研)独资的一人有限责任公司,是农业部禽流感疫苗生产企业和技术依托单位。

维科生物成立于1992年,专门从事动物疫病防治用生物制品的研发、生产、销售、技术咨询与服务,是具有独立法人资格的企业,主要是对哈兽研科技成果进行孵化、转化及孵化后的推广。

维科生物现有员工中具有大专以上学历人员超过70%,其中高级职称人员4人,副高级职称人员21人,具有博士、硕士以上学位人员62人。中高级职称人员中,绝大多数是哈兽研所获科技成果的完成人。

公司新址落成于2008年,并于2009年7月整体通过农业部兽用生物制品GMP验收。新址园区面积约11.4万平方米,建筑面积6.2万平方米,共有17条生产线,主要设备为进口,自动化程度高,工艺优良。另有国家禽流感疫苗抗原储备库、质量检验、研发、动物实验、立体仓储等配套设施。

依托维科生物的黑龙江兽用生物制品工程技术研究中心与哈尔滨市兽用生物制品工程研究中心运行良好。经国家发改委立项与批准,维科生物参股组建的动物用生物制品国家工程研究中心也已正式运行。

维科生物生产的历代禽流感疫苗均在禽流感疫情防控中得到了广泛应用,解决了不同禽种的有效免疫问题,为我国禽流感疫情的防控做出重要贡献。目前维科生物的禽流感疫苗已在越南、埃及、印尼广泛应用。

我公司秉承“团结、奉献、求实、创新”的哈兽研精神,本着“责任重于泰山,细节决定成败”的企业文化理念,以维护动物健康和保障动物性食品安全为宗旨,以追踪兽用生物制品技术前沿为目标,高起点地为畜牧业发展服务,并努力将企业发展成为出色的兽用生物制品企业。


Founded in 1992, Harbin Weike Biotechnology Co., Ltd. (hereinafter referred to as "Weike biotechnology") is a famous brand of avian influenza vaccine manufacturing in China, specializing in the R & D, production, sales, technical consultation and service of biological products for animal disease prevention and control. It is a wholly-owned one person limited liability company of Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences (hereinafter referred to as "Harbin Veterinary Research") The company is an avian influenza vaccine manufacturer and technical support unit of the Ministry of agriculture. Founded in 1992, Vico biology specializes in the R & D, production, sales, technical consultation and service of biological products for animal disease prevention and control. It is an enterprise with independent legal personality, which mainly incubates, transforms and promotes the scientific and technological achievements of Harbin animal research. At present, more than 70% of the employees have college degree or above, including 4 with senior professional title, 21 with deputy senior professional title, 62 with doctor's degree or above. Most of the middle and senior professional titles are the Achievers of scientific and technological achievements of Harbin animal research institute. The company's new site was completed in 2008 and passed the GMP acceptance of animal biological products by the Ministry of agriculture in July 2009. The new site covers an area of about 114000 square meters, with a building area of 62000 square meters. There are 17 production lines. The main equipment is imported, with high degree of automation and excellent technology. There are also national avian influenza vaccine antigen storage, quality inspection, research and development, animal experiments, three-dimensional storage and other supporting facilities. Heilongjiang animal biological products engineering technology research center and Harbin animal biological products Engineering Research Center Based on Vico biology are in good operation. With the approval of the national development and Reform Commission, the National Engineering Research Center for animal biological products, which was established with the participation of Vico biology, has also been officially put into operation. All the avian influenza vaccines produced by Vico biology have been widely used in the prevention and control of avian influenza epidemic, which solved the effective immune problems of different avian species and made important contributions to the prevention and control of avian influenza epidemic in China. At present, the avian influenza vaccine of vyco has been widely used in Vietnam, Egypt and Indonesia. Our company adheres to the spirit of "unity, dedication, truth-seeking and innovation", the corporate culture concept of "responsibility is more important than Mount Tai, details determine success or failure", the purpose of maintaining animal health and ensuring animal food safety, the goal of tracking the forefront of animal biological products technology, the high starting point for animal husbandry development services, and strive to develop the enterprise into an excellent animal use Biological products enterprises.

本文链接: https://brand.waitui.com/19aeb19ab.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

IBM计划未来五年在美国投资1500亿美元

IBM宣布计划在未来五年内在美国投资1500亿美元,以推动经济并加速其作为全球计算领导者的地位。这包括超过300亿美元的研发投资,以推进和继续 IBM 在美国制造大型机和量子计算机。(财联社)

2小时前

美股大型科技股盘前涨跌不一,特斯拉涨超1%

36氪获悉,美股大型科技股盘前涨跌不一,截至发稿,特斯拉、Meta涨超1%,亚马逊涨0.72%,苹果涨0.36%,谷歌涨0.29%,微软涨0.01%;英伟达跌超1%,Arm跌0.48%,奈飞跌0.32%。

2小时前

热门中概股美股盘前涨跌不一,蔚来涨超1%

36氪获悉,热门中概股美股盘前涨跌不一,截至发稿,蔚来、理想汽车涨超1%,京东涨0.69%,微博涨0.25%;百度、B站跌超1%,阿里巴巴跌0.58%,拼多多跌0.12%。

2小时前

北汽蓝谷:一季度净亏损9.53亿元

36氪获悉,北汽蓝谷发布一季度财报。报告显示,2025年第一季度营业收入37.73亿元,同比增长150.75%,归属于上市公司股东的净利润为-9.53亿元。营业收入增长主要系报告期整车销量同比增加所致。

2小时前

ST春天:4月30日起被实施退市风险警示,明日停牌一天

36氪获悉,ST春天公告,因公司2024年度的利润总额、净利润或者扣除非经常性损益后的净利润孰低者为负值且扣除与主营业务无关的业务收入和不具备商业实质的收入后的营业收入低于3亿元,公司股票将被实施退市风险警示。公司股票将于2025年4月29日停牌1天,2025年4月30日起实施退市风险警示,股票简称由“ST春天”变更为“*ST春天”,实施后股票价格的日涨跌幅限制为5%。

2小时前

本页详细列出关于哈兽研的品牌信息,含品牌所属公司介绍,哈兽研所处行业的品牌地位及优势。
咨询